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Introduction
Lithium-related neurological toxicity may be severe result-
ing in seizures, myoclonic encephalopathy, and coma.
Three different poisoning presentations exist in humans,
including acute poisoning in non-previously treated
patients (A), acute-on-chronic poisoning (A/C), and thera-
peutic overdose (T). The exact reasons why severity and
features are different between these three presentations
are unknown, although differences in brain lithium distri-
bution have been suggested.
Objectives
Our objective was to study lithium pharmacokinetics in
blood and brain in rat models corresponding to each
human presentation.
Methods
Development of three models of lithium intoxication in
Sprague Dawley rats: A (one intraperitoneal injection of
185 mg/kg Li2CO3); A/C (800 or 1600 mg/L Li2CO3 in
the drinking water followed by one intraperitoneal injec-
tion of 185 mg/kg Li2CO3 at day 28); T (K2Cr2O7-induced
acute renal failure on day 1 followed by intraperitoneal
injections of 74 mg/kg/day Li2CO3 during 5 days); deter-
mination of plasma, erythrocyte, cerebrospinal fluid, and
brain lithium concentrations using inductively coupled
plasma atomic emission spectroscopy (quantification
threshold: 0.6 nmol/L); modeling and determination of
pharmacokinetics parameters; comparisons with non-
parametric tests.
Results
Lithium followed a tricompartmental pharmacokinetics
with a shortened plasma half-life in case of previous
chronic exposure (1.73 vs. 3.85h). The peak lithium con-
centration was measured at 6h in erythrocytes, 2h in cere-
brospinal fluid, and 24h in the brain in both A and A/C
models; however, the elimination constants k21 (erythro-
cytes-to-plasma) and k31 (brain-to-plasma) were lower in
the A/C model (0.36 versus 0.56 and 2.1 versus 9.2, respec-
tively), suggesting lithium accumulation. The brain distri-
bution was not homogeneous, with rapid entrance (as
soon as 15min), peak at 24h, and delayed elimination
(>78h). Lithium accumulation into the brain was more
marked in the presence of previous chronic exposure
(brain-to-plasma ratio at 54h: 131.27 vs. 6.42; p< 0.0001).
Similarly, alteration in renal elimination resulted in
increased brain distribution (brain-to-plasma ratio: 10.98
vs. 6.88).
Conclusions
Our experimental models suggest that the three different
presentations of lithium poisonings in humans differ due
to lithium blood pharmacokinetics and brain distribution.
However, the hypothesis of an additional variability related
to different interactions of lithium with neurological
targets in each presentation could not be ruled out.
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